About PrimeVax Immuno-Oncology

About company

PrimeVax Immuno-Oncology is developing a multi-mechanism treatment for cancer leveraging whole body systemic fever along with personalized neo-antigens. Our therapeutic design is to be the only one-time one-week cancer treatment. They combine dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting. We focus on cancer cells resistant to prior treatments.